| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3451052 | Archives of Physical Medicine and Rehabilitation | 2010 | 7 Pages |
Abstract
This study showed the feasibility and safety of testing SMF therapy for CTS. There were no between-group differences observed for the BCTQ or median nerve parameters after 6 weeks of SMF therapy. Significant within-group, symptomatic improvements of the same magnitude were experienced by participants in both active and sham magnet groups. Future studies are needed to optimize SMF dosimetry and resolve issues related to the use of sham controls in SMF trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Agatha P. MD, Marko S. PhD, Nels MD, William L. PhD, Hans MD, Patricia J. PhD,